For the past several years, success has grown more elusive for American biotech firms. Even in the more robust investment climates prior to 2022, developing and growing a biotech always required a combination of risk appetite and patient capital that did not lend itself to the rapid exits typical of other areas of tech investing. …
4 DNA sequencing predictions for 2023
Continued innovations in bioinformatics paired with the falling cost of DNA sequencing are poised to spur research breakthroughs in 2023. To gauge how the DNA sequencing field is likely to evolve, we reached out to Logan Zinser, SVP, finance, Element Biosciences and Keith Robison, principal engineer, NGS Computational Biology, Ginkgo Bioworks. In the following feature, the two muse on themes…
Good-bye outsourcing, hello in-house science: how innovation is giving scientists more control at the bench
Ten years ago, as a Ph.D. student fellow at Indiana University studying the evolution of prokaryotes, the cheapest and easiest way for me to sequence some microbes was to send them halfway around the world to China. Even with quick shipping and no problems with the sequencing, it could take up to a month for…


